Cure Bionics

Cure Bionics specializes in prosthetic upper-limb devices. Their primary product, the Hannibal Hand, is a powered or semi-powered artificial hand designed to restore functional movement for individuals with limb loss or severe impairment. This device focuses on improving dexterity and control compared to traditional passive prosthetics.

Cure Bionics is based in Tennessee, USA. Their devices, including the Hannibal Hand, are registered in the EU’s eudamed database, which is the official EU registry for medical devices. This registration ensures transparency and compliance with EU regulatory requirements.

The Hannibal Hand, Cure Bionics’ primary device, is classified as a Class I medical device. This classification is typically assigned to low-risk devices that pose minimal risk to users, though compliance with applicable regulations remains essential for market authorization.

The Hannibal Hand incorporates powered or semi-powered functionality to address limitations of passive prosthetics, which rely solely on mechanical movement without active control. By providing enhanced dexterity and user-controlled motion, it aims to improve daily living activities for individuals with limb loss or severe impairment, offering a more adaptive solution.